Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Parkinson's Disease: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Parkinson's Disease is a disease characterized by neurodegeneration research. Key relationships include: associated with, risk factor for, involved in. Associated with Chronic Viral Infections, Rapid Eye Movement Sleep Behavior Disorder. Connected to 130 entities in the SciDEX knowledge graph.
| Associated Genes | SNCA, SLC6A3, NDUFA9, Alpha-Synuclein, LAMP1, IGF2, TMEM175, α-Synuclein |
| Therapeutic Agents | Nsaid, Methylene Blue, Atremorine, Gentiopicroside, ACLY Inhibitor, ACLY Inhibitors |
| KG Connections | 1037 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
Parkinson_s_Disease["Parkinson's Disease"] -->|"associated"| Dopaminergic_Neurons["Dopaminergic Neurons"]
Parkinson_s_Disease["Parkinson's Disease"] -->|"associated"| Substantia_Nigra["Substantia Nigra"]
Parkinson_s_Disease["Parkinson's Disease"] -->|"causes"| Motor_Decline["Motor Decline"]
Parkinson_s_Disease["Parkinson's Disease"] -->|"causes"| Cognitive_Decline["Cognitive Decline"]
Parkinson_s_Disease["Parkinson's Disease"] -->|"causes"| Neurodegeneration["Neurodegeneration"]
Parkinson_s_Disease["Parkinson's Disease"] -->|"associated"| Circadian_Rhythm["Circadian Rhythm"]
SNCA["SNCA"] -->|"associated"| Parkinson_s_Disease["Parkinson's Disease"]
SNCA_1["SNCA"] -->|"causes"| Parkinson_s_Disease["Parkinson's Disease"]
Prosaposin_GPR37_IL_6_Axis["Prosaposin-GPR37-IL-6 Axis"] -->|"involved in"| Parkinson_s_Disease["Parkinson's Disease"]
Gut_Microbiota["Gut Microbiota"] -->|"associated"| Parkinson_s_Disease["Parkinson's Disease"]
style Parkinson_s_Disease fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Dopaminergic Neurons | associated_with | cell_type | 0.95 |
| Substantia Nigra | associated_with | cell_type | 0.95 |
| Motor Decline | causes | phenotype | 0.95 |
| Cognitive Decline | causes | phenotype | 0.95 |
| Neurodegeneration | causes | process | 0.95 |
| Circadian Rhythm | associated_with | process | 0.95 |
| Neuroinflammation | associated_with | process | 0.95 |
| Toxic Protein Accumulation | associated_with | process | 0.95 |
| Dopaminergic Neurons | causes | cell_type | 0.95 |
| Dopaminergic Neuron Loss | causes | process | 0.95 |
| Dopaminergic Neurodegeneration | causes | process | 0.95 |
| Neurodegenerative Diseases | associated_with | disease | 0.95 |
| bradykinesia | causes | phenotype | 0.95 |
| dopaminergic neurons | causes | cell_type | 0.95 |
| cognitive impairment | causes | phenotype | 0.95 |
| dopaminergic system | associated_with | pathway | 0.93 |
| Inflammatory Processes | associated_with | process | 0.90 |
| Type 2 Diabetes Mellitus | associated_with | disease | 0.90 |
| Depression | associated_with | disease | 0.90 |
| Neurons | targets | cell_type | 0.90 |
| Iron Accumulation | associated_with | process | 0.90 |
| akinesia | causes | phenotype | 0.90 |
| omission rate | associated_with | phenotype | 0.90 |
| Insulin Resistance | associated_with | process | 0.85 |
| Brain-Resident T Cells | associated_with | cell_type | 0.85 |
| Levodopa Response | correlates_with | phenotype | 0.85 |
| motor incoordination | causes | phenotype | 0.85 |
| functional performance | suppresses | phenotype | 0.85 |
| dorsolateral prefrontal cortex | associated_with | brain_region | 0.85 |
| Short-Chain Fatty Acids | correlates_with | compound | 0.80 |
| basal ganglia-thalamocortical circuit | associated_with | biological_process | 0.80 |
| prefrontal interhemispheric functional connectivity | modulates | phenotype | 0.80 |
| Adverse Drug Reactions | associated_with | phenotype | 0.75 |
| MAPL | associated_with | protein | 0.75 |
| Inflammation | associated_with | process | 0.75 |
| Vitamin D | associated_with | chemical | 0.70 |
| Neurodegenerative Diseases | interacts_with | disease | 0.50 |
| disease | interacts_with | disease | 0.50 |
| PARKINSON'S | interacts_with | concept | 0.50 |
| Pain | interacts_with | disease | 0.50 |
| Neuropathy | associated_with | disease | 0.50 |
| disease | associated_with | disease | 0.50 |
| ALZHEIMER'S | associated_with | concept | 0.50 |
| PARKINSON'S | associated_with | concept | 0.50 |
| ALZHEIMER'S | interacts_with | concept | 0.50 |
| Neuron | protects_against | cell_type | 0.50 |
| disease | protects_against | disease | 0.50 |
| NEURONS | protects_against | concept | 0.50 |
| Substantia Nigra | protects_against | entity | 0.50 |
| PARKINSON'S | protects_against | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SNCA | associated_with | gene | 0.95 |
| SNCA | causes | gene | 0.95 |
| Prosaposin-GPR37-IL-6 Axis | involved_in | pathway | 0.95 |
| Gut Microbiota | associated_with | process | 0.95 |
| GBA | risk_factor_for | gene | 0.95 |
| SNCA | risk_factor_for | gene | 0.95 |
| LRRK2 | risk_factor_for | gene | 0.95 |
| PRKN | risk_factor_for | gene | 0.95 |
| PINK1 | risk_factor_for | gene | 0.95 |
| DJ1 | risk_factor_for | gene | 0.95 |
| Neuroinflammation | contributes_to | process | 0.95 |
| Alpha-Synuclein | involved_in | protein | 0.95 |
| C3 | involved_in | protein | 0.95 |
| α-Synuclein | causes | protein | 0.95 |
| SNCA | involved_in | gene | 0.95 |
| SNCA | component_of | protein | 0.95 |
| Mptp | causes | drug | 0.95 |
| Mitochondrial Dysfunction | contributes_to | process | 0.95 |
| Neuroinflammation | biomarker_for | process | 0.95 |
| Circadian Clock | associated_with | process | 0.95 |
| Α-SYNUCLEIN | causes | protein | 0.95 |
| LRRK2 | causes | gene | 0.95 |
| GBA1 | causes | gene | 0.95 |
| PRKN | causes | gene | 0.95 |
| PINK1 | causes | gene | 0.95 |
| PARK7 | causes | gene | 0.95 |
| VPS35 | causes | gene | 0.95 |
| Dopaminergic Neurons | involved_in | cell_type | 0.95 |
| Alpha-Synuclein Accumulation | contributes_to | process | 0.95 |
| Alpha-Synuclein Aggregation | causes | mechanism | 0.95 |
| Alpha-Synuclein Aggregation | associated_with | process | 0.95 |
| Dopaminergic Neuronal Death | causes | process | 0.95 |
| PINK1 | associated_with | gene | 0.95 |
| PRKN | associated_with | gene | 0.95 |
| ALPHA-SYNUCLEIN | involved_in | protein | 0.95 |
| Neurodegeneration | contributes_to | process | 0.95 |
| Pathological Processes | contributes_to | process | 0.95 |
| Neuroplasticity | associated_with | process | 0.95 |
| Rotenone | causes | compound | 0.95 |
| ALPHA-SYNUCLEIN AGGREGATES | contributes_to | protein | 0.95 |
| Levodopa | treats | drug | 0.95 |
| Pathological Protein Aggregation | causes | process | 0.95 |
| 6-Ohda | causes | compound | 0.95 |
| ALPHA-SYNUCLEIN | associated_with | protein | 0.95 |
| LRRK2 | contributes_to | gene | 0.95 |
| GBA1 | contributes_to | gene | 0.95 |
| PRKN | contributes_to | gene | 0.95 |
| PINK1 | contributes_to | gene | 0.95 |
| PARK7 | contributes_to | gene | 0.95 |
| VPS35 | contributes_to | gene | 0.95 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.632
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.467
neurodegeneration | 2026-04-01 | 0 hypotheses
neurodegeneration | 2026-04-01 | 0 hypotheses
neurodegeneration | 2026-04-01 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||